Mirabella, Massimiliano
 Distribuzione geografica
Continente #
EU - Europa 5.154
NA - Nord America 5.102
AS - Asia 1.129
AF - Africa 57
SA - Sud America 27
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 11
Totale 11.494
Nazione #
US - Stati Uniti d'America 5.074
DE - Germania 1.862
SE - Svezia 1.165
CN - Cina 635
IT - Italia 465
UA - Ucraina 439
IE - Irlanda 320
FR - Francia 228
SG - Singapore 213
PL - Polonia 155
GB - Regno Unito 151
IN - India 127
RU - Federazione Russa 119
FI - Finlandia 112
CI - Costa d'Avorio 48
TR - Turchia 41
BE - Belgio 36
VN - Vietnam 27
JP - Giappone 25
IR - Iran 23
CA - Canada 22
NL - Olanda 15
CZ - Repubblica Ceca 12
ES - Italia 12
AU - Australia 11
BR - Brasile 10
RO - Romania 10
CH - Svizzera 9
KR - Corea 9
A2 - ???statistics.table.value.countryCode.A2??? 8
CL - Cile 8
HK - Hong Kong 8
PT - Portogallo 6
DK - Danimarca 5
AT - Austria 4
CO - Colombia 4
HU - Ungheria 4
IL - Israele 4
BG - Bulgaria 3
CU - Cuba 3
EE - Estonia 3
HR - Croazia 3
MD - Moldavia 3
MX - Messico 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
EG - Egitto 2
EU - Europa 2
GR - Grecia 2
IQ - Iraq 2
KZ - Kazakistan 2
MK - Macedonia 2
PE - Perù 2
PH - Filippine 2
PS - Palestinian Territory 2
ZA - Sudafrica 2
A1 - Anonimo 1
AM - Armenia 1
AR - Argentina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DZ - Algeria 1
EC - Ecuador 1
KE - Kenya 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MA - Marocco 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
NP - Nepal 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 11.494
Città #
Chandler 1.168
Ashburn 421
Dublin 315
Jacksonville 292
San Mateo 266
Wilmington 171
Ann Arbor 161
Nanjing 156
New York 155
Nürnberg 150
Warsaw 147
Boston 124
Singapore 114
Houston 106
Redmond 104
Princeton 97
Woodbridge 97
Dearborn 95
Moscow 85
Beijing 79
Lawrence 72
Cattolica 66
Fairfield 64
Milan 64
Nanchang 62
Redwood City 60
Seattle 58
Rome 56
Marseille 54
Bremen 52
Abidjan 48
Chicago 48
Norwalk 45
Hebei 35
Izmir 35
Brussels 32
Detroit 30
Mountain View 30
Munich 29
University Park 29
Pune 26
Kunming 25
Leawood 25
Boardman 24
Shenyang 23
Guangzhou 20
Jiaxing 20
Tianjin 20
Hangzhou 18
Changsha 17
Los Angeles 17
Falls Church 16
Fremont 16
Helsinki 16
Shanghai 14
Washington 12
Zhengzhou 12
Cambridge 11
Florence 11
Hanoi 9
London 9
Phoenix 9
Simi Valley 9
Andover 8
Auburn Hills 8
Changchun 8
Edinburgh 8
Hefei 8
Lancaster 8
Philadelphia 8
Busto Arsizio 7
Fairport 7
Hounslow 7
Indiana 7
Jinan 7
Lappeenranta 7
Toronto 7
Ardabil 6
Atlanta 6
Bari 6
Berlin 6
Mola di Bari 6
Saint Louis 6
San Jose 6
Seoul 6
São Paulo 6
Tokyo 6
Zurich 6
Amsterdam 5
Augusta 5
Buffalo 5
Landshut 5
Lisbon 5
Lviv 5
Melbourne 5
Tehran 5
Verona 5
Avon 4
Bogotá 4
Brdo 4
Totale 5.879
Nome #
MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle. 316
Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis 259
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis 207
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 193
Primary fibroblasts cultures reveal TDP-43 abnormalities in amyotrophic lateral sclerosis patients with and without SOD1 mutations 186
CD8(+) T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI 155
T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis. 150
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 146
Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies 142
alpha-Dystroglycan does not play a major pathogenic role in autosomal recessive hereditary inclusion-body myopathy 139
Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma 135
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. 132
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 127
Muscle imaging findings in GNE myopathy 123
Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients. 122
A Case of Hemiabdominal Myoclonus 119
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 117
Sleep Disordered Breathing in a cohort of patients with sporadic Inclusion Body Myositis. 112
Mesoangioblasts from Facioscapulohumeral Muscular Dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior. 109
An Italian family with inclusion-body myopathy and frontotemporal dementia due to mutation in the VCP gene 109
Acyclovir-related kidney injury during alemtuzumab infusion 108
A human anti-Neuronal Autoantibody Against GABAB Receptor induces Experimental Autoimmune Agrypnia 107
Low reliability of anti-KIR4.183-120 peptide auto-antibodies in multiple sclerosis patients 103
Muscle MRI in female carriers of dystrophinopathy 98
Idiopathic inflammatory myopathies evaluated by near infrared spectroscopy 97
Hereditary inclusion-body myopathy with sparing of the quadriceps: the many tiles of an incomplete puzzle 96
Intravascular large B-cell lymphoma presenting as slowly progressive paraparesis with normal MRI features 95
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 93
Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle 92
Severe disability in patients with relapsing-remitting multiple sclerosis is associated with profound changes in the regulation of leptin secretion 92
Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles 91
Sleep disorder associated with antibodies to IgLON5: parasomnia or agrypnia? 90
Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia. 88
Coeliac disease presenting with acute disseminated encephalomyelitis 87
The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis. 87
Analysis of NCAM helps identify unusual phenotypes of hereditary inclusion-body myopathy 86
Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis 85
IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. 84
Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort 83
TWEAK in inclusion-body myositis muscle: possible pathogenic role of a cytokine inhibiting myogenesis 80
Neprilysin participates in skeletal muscle regeneration and is accumulated in abnormal muscle fibres of inclusion body myositis. 79
Case of postpartum Parsonage-Turner syndrome 79
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis 79
Hereditary inclusion-body myopathy: clues on pathogenesis and possible therapy 78
Effects of rehabilitation treatment of the upper limb in Multiple Sclerosis patients and predictive value of neurophysiological measures 77
A Case of Hemiabdominal Myoclonus 74
ANCA-related vasculitic neuropathy mimicking motor neuron disease. 73
Cerebellar degeneration and ocular myasthenia gravis in a patient with recurring ovarian carcinoma. 73
Bilateral thoracic long nerve involvement in motor multifocal neuropathy 73
Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems 73
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 73
Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception 72
Coeliac disease presenting with acute disseminated encephalomyelitis. 71
Response to the letter to the Editor for the manuscript “Sleep and Fatigue in Multiple Sclerosis: A questionnaire-based, cross-sectional, cohort study” by Tomoyuki Kawada 71
An Italian case of hereditary myopathy with early respiratory failure (HMERF) not associated with the titin kinase domain R279W mutation 70
Regulatory T cells fail to suppress CD4(+)T-bet(+) T cells in relapsing multiple sclerosis patients 70
Oculopharyngeal muscular dystrophy: Clinical and neurophysiological features 70
Fingolimod vs dimethyl fumarate in multiple sclerosis 70
An atypical case of acute disseminated encephalomyelitis associated with cytomegalovirus infection 69
An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene 68
Sleep and fatigue in multiple sclerosis: A questionnaire-based, cross-sectional, cohort study 68
Relapsing-remitting autoimmune agrypnia 67
Clinical characteristics, course and prognosis of spinal multiple sclerosis 67
Lower motor neuron involvement in longitudinally extensive transverse myelitis with and without aquaporin-4 antibodies 67
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients 66
Long-term Follow-up and Muscle Imaging Findings in Brachio-Cervical Inflammatory Myopathy 65
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 64
Novel SEC61G-EGFR fusion gene in pediatric ependymomas discovered by clonal expansion of stem cells in absence of exogenous mitogens 63
Mesoangioblasts of inclusion-body myositis: a twofold tool to study pathogenic mechanisms and enhance defective muscle regeneration 62
Increased aging in primary muscle cultures of sporadic inclusion-body myositis. 62
gc)Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 62
Low reliability of anti-KIR4.183–120peptide auto-antibodies in multiple sclerosis patients 62
Dominus effect: challenging complications of alemtuzumab-related thyroid autoimmunity 62
Defining the disease course of TNFα blockers-associated Multiple Sclerosis 61
Hereditary inclusion-body myopathies 60
Magnetic resonance imaging pattern recognition in sporadic Inclusion-Body Myositis 60
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis. 60
In vivo effect of Mitoxantrone on the production of pro- and anti-inflammatory cytokines by peripheral blood mononuclear cells of secondary progressive multiple sclerosis patients 59
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis 59
A TLR/CD44 axis regulates T cell trafficking in experimental and human multiple sclerosis 59
Pilot trial of simvastatin in the treatment of sporadic inclusion-body myositis 58
Neurotriphic factor in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy 58
Rasmussen encephalitis: an unusual cause for intractable seizures in elderly 58
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 57
Vessel-associated stem cells from skeletal muscle: From biology to future uses in cell therapy 56
pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity 56
Lower urinary tract disorders in multiple sclerosis patients: prevalence, clinical features, and response to treatments 56
Evidence of involvement of leptin and IL-6 peptides in the action of interferon-beta in secondary progressive multiple sclerosis 55
Correction: BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression(PLoS ONE (2018) 1310 (e0206140) DOI: 10.1371/journal.pone.0206140) 55
Mixed connective tissue disease presenting as a peculiar myositis with poor muscle regeneration 55
BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression 54
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 54
Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta 53
Focal muscle vibration, an effective rehabilitative approach in severe gait impairment due to multiple sclerosis 53
Acyclovir-related kidney injury during alemtuzumab infusion 52
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 52
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatment 51
Chapter 28- Hereditary Inclusion-Body Myopathies 51
A unique case of multiphasic ADEM or what else? 50
Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. 49
Totale 8.740
Categoria #
all - tutte 49.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.505 263 107 103 63 124 137 115 49 116 104 212 112
2020/20211.105 33 100 27 95 120 65 101 45 118 92 280 29
2021/20221.616 135 100 33 197 50 59 46 250 97 84 245 320
2022/20233.242 383 432 266 466 226 431 149 276 390 49 123 51
2023/20241.648 62 466 60 120 53 224 115 70 24 57 181 216
2024/202563 63 0 0 0 0 0 0 0 0 0 0 0
Totale 11.712